NovoCure Ltd — Director's Dealing 2018

Jun 7, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2018-06-04

Reporting Person: Danziger Asaf (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-04	Ordinary Shares	S	149878	$28.43	Disposed	260246	Direct
2018-06-04	Ordinary Shares	S	26782	$29.31	Disposed	233464	Direct
2018-06-04	Ordinary Shares	S	28150	$30.34	Disposed	205314	Direct
2018-06-04	Ordinary Shares	S	19694	$31.64	Disposed	185620	Direct
2018-06-04	Ordinary Shares	S	2800	$32.00	Disposed	182820	Direct

Footnotes

F1: On June 4, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 149,878 shares in multiple trades at prices ranging from $28.00 to $28.95. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F2: On June 4, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 26,782 shares in multiple trades at prices ranging from $29.00 to $29.95. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F3: On June 4, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 28,150 shares in multiple trades at prices ranging from $30.00 to $30.95. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F4: On June 4, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 19,694 shares in multiple trades at prices ranging from $31.00 to $31.975. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F5: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger.